$ARDX
ARDELYX, INC.

2015 Q4 Form 10-Q Financial Statement

#000119312515375641 Filed on November 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $0.00 $0.00 $7.598M
YoY Change -100.0% -100.0% 15.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.090M $3.370M $1.820M
YoY Change 41.52% 85.16% 102.22%
% of Gross Profit
Research & Development $12.78M $14.71M $5.694M
YoY Change 72.94% 158.25% -13.47%
% of Gross Profit
Depreciation & Amortization $290.0K $260.0K $70.00K
YoY Change 190.0% 271.43% -53.33%
% of Gross Profit
Operating Expenses $16.88M $18.08M $7.517M
YoY Change 64.32% 140.51% 0.51%
Operating Profit -$18.08M $81.00K
YoY Change -22419.75% -109.14%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit 0.0%
Other Income/Expense, Net -$120.0K -$77.00K -$7.000K
YoY Change -500.0% 1000.0% -30.0%
Pretax Income -$17.00M -$18.16M $74.00K
YoY Change 335.9% -24635.14% -108.23%
Income Tax $0.00 -$30.00K $0.00
% Of Pretax Income 0.0%
Net Earnings -$17.00M -$18.13M $74.00K
YoY Change 328.21% -24594.59% -107.92%
Net Earnings / Revenue 0.97%
Basic Earnings Per Share -$0.65 -$0.70 $0.00
Diluted Earnings Per Share -$0.65 -$0.70 $0.00
COMMON SHARES
Basic Shares Outstanding 25.96M shares 25.93M shares 18.37M shares
Diluted Shares Outstanding 25.93M shares 19.13M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.0M $129.0M $112.0M
YoY Change -0.28% 15.18%
Cash & Equivalents $107.0M $129.0M $112.0M
Short-Term Investments
Other Short-Term Assets $5.000M $4.400M $1.700M
YoY Change 316.67% 158.82%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $2.660M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $112.0M $133.5M $116.4M
YoY Change 0.86% 14.69%
LONG-TERM ASSETS
Property, Plant & Equipment $4.711M $4.391M $1.152M
YoY Change 121.07% 281.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.0K $104.0K $200.0K
YoY Change 0.0% -48.0%
Total Long-Term Assets $4.915M $4.595M $1.356M
YoY Change 110.49% 238.86%
TOTAL ASSETS
Total Short-Term Assets $112.0M $133.5M $116.4M
Total Long-Term Assets $4.915M $4.595M $1.356M
Total Assets $116.9M $138.1M $117.7M
YoY Change 3.11% 17.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.777M $2.714M $1.022M
YoY Change -11.25% 165.56%
Accrued Expenses $1.328M $1.700M $1.900M
YoY Change -44.67% -10.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.723M $12.58M $19.40M
YoY Change -64.14% -35.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $322.0K $352.0K $35.00M
YoY Change 163.93% -98.99%
Total Long-Term Liabilities $322.0K $352.0K $35.00M
YoY Change 163.93% -98.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.723M $12.58M $19.40M
Total Long-Term Liabilities $322.0K $352.0K $35.00M
Total Liabilities $8.045M $12.94M $54.43M
YoY Change -84.74% -76.23%
SHAREHOLDERS EQUITY
Retained Earnings -$101.5M -$84.49M -$67.90M
YoY Change 41.22% 24.44%
Common Stock $210.4M $209.6M $2.000K
YoY Change 58.73% 10480800.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $108.9M $125.1M $63.30M
YoY Change
Total Liabilities & Shareholders Equity $116.9M $138.1M $117.7M
YoY Change 3.11% 17.27%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$17.00M -$18.13M $74.00K
YoY Change 328.21% -24594.59% -107.92%
Depreciation, Depletion And Amortization $290.0K $260.0K $70.00K
YoY Change 190.0% 271.43% -53.33%
Cash From Operating Activities -$21.60M -$11.81M -$5.680M
YoY Change 469.92% 107.92% 2740.0%
INVESTING ACTIVITIES
Capital Expenditures -$450.0K -$680.0K -$80.00K
YoY Change -56.73% 750.0% 300.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$450.0K -$680.0K -$80.00K
YoY Change -56.73% 750.0% 300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 0.000 0.000
YoY Change -85.71%
NET CHANGE
Cash From Operating Activities -21.60M -11.81M -5.680M
Cash From Investing Activities -450.0K -680.0K -80.00K
Cash From Financing Activities 10.00K 0.000 0.000
Net Change In Cash -22.04M -12.49M -5.760M
YoY Change 363.03% 116.84% 2518.18%
FREE CASH FLOW
Cash From Operating Activities -$21.60M -$11.81M -$5.680M
Capital Expenditures -$450.0K -$680.0K -$80.00K
Free Cash Flow -$21.15M -$11.13M -$5.600M
YoY Change 669.09% 98.75% 3011.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25956941 shares
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112044000
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.125
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2172899 shares
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.70
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25954941 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25954941 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
209615000
CY2015Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8173000
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1697000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
125130000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
352000
CY2015Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
845000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2714000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84488000
CY2015Q3 us-gaap Liabilities
Liabilities
12936000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138066000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12584000
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2015Q3 us-gaap Assets
Assets
138066000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4391000
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
133471000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4424000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129047000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34435000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18589245 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18589245 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132547000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
780000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1648000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60682000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
122000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
780000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15979000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3129000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71867000
CY2014Q4 us-gaap Liabilities
Liabilities
52732000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113414000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31074000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21536000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2014Q4 us-gaap Assets
Assets
113414000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2584000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2131000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
111079000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1209000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107286000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17189000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7476642 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7476642 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
10775000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
824000
us-gaap Net Income Loss
NetIncomeLoss
757000
us-gaap Revenues
Revenues
25284000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
370000
us-gaap Operating Income Loss
OperatingIncomeLoss
2369000
us-gaap Licenses Revenue
LicensesRevenue
14509000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3776000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
757000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Share Based Compensation
ShareBasedCompensation
484000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1593000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
757000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11141000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
689000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
77609000
us-gaap Operating Expenses
OperatingExpenses
22915000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-824000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
61244000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18514000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61241000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
179000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
484000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4401000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1262000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Depreciation
Depreciation
202000
ardx Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-50237000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001437402
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Ardelyx, Inc.
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21859383 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21859383 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Use of Estimates</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although management believes these estimates are based upon reasonable assumptions within the bounds of its knowledge of the Company&#x2019;s business and operations, actual results could differ materially from those estimates.</p> </div>
dei Trading Symbol
TradingSymbol
ARDX
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2415000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000000
us-gaap Net Income Loss
NetIncomeLoss
-12621000
us-gaap Revenues
Revenues
24026000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3107000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12513000
us-gaap Licenses Revenue
LicensesRevenue
21611000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-138000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2584000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-64000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12651000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
69000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30000
us-gaap Share Based Compensation
ShareBasedCompensation
1877000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47053000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
7624000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21761000
us-gaap Operating Expenses
OperatingExpenses
36539000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
74998000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27101000
CY2015Q2 ardx Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
77800000
CY2015Q2 ardx Warrant Expiration Term
WarrantExpirationTerm
P5Y
CY2015Q2 ardx Class Of Warrant Or Right Threshold Ownership Percentage
ClassOfWarrantOrRightThresholdOwnershipPercentage
0.0999 pure
CY2015Q3 ardx Payment Received On Termination Of Option And License Agreement
PaymentReceivedOnTerminationOfOptionAndLicenseAgreement
0
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
ardx Class Of Warrant Or Right Expiration Date Description
ClassOfWarrantOrRightExpirationDateDescription
The warrants are exercisable for an exercise price of $13.91 per share at any time prior to the earlier of (i) 5 years from the date of issuance or (ii) certain changes in control of the Company.
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7242992 shares
CY2015Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
13.91
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74300000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74322000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
48000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
646000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1877000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9438000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
88000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-281000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000
us-gaap Depreciation
Depreciation
540000
ardx Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
ardx Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-12621000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19133217 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
758940 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18374277 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2014Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2831000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
74000
CY2014Q3 us-gaap Revenues
Revenues
7598000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
81000
CY2014Q3 us-gaap Licenses Revenue
LicensesRevenue
4767000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74000
CY2014Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
7517000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5694000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
322000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1823000
CY2014Q3 ardx Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
74000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25930928 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25930928 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-18126000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18079000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-77000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18156000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30000
CY2015Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
18079000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14705000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
712000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3374000
CY2015Q3 ardx Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
CY2015Q3 ardx Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-18126000

Files In Submission

Name View Source Status
0001193125-15-375641-index-headers.html Edgar Link pending
0001193125-15-375641-index.html Edgar Link pending
0001193125-15-375641.txt Edgar Link pending
0001193125-15-375641-xbrl.zip Edgar Link pending
ardx-20150930.xml Edgar Link completed
ardx-20150930.xsd Edgar Link pending
ardx-20150930_cal.xml Edgar Link unprocessable
ardx-20150930_def.xml Edgar Link unprocessable
ardx-20150930_lab.xml Edgar Link unprocessable
ardx-20150930_pre.xml Edgar Link unprocessable
d94202d10q.htm Edgar Link pending
d94202dex311.htm Edgar Link pending
d94202dex312.htm Edgar Link pending
d94202dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending